WGS GeneDx Holdings Corp.
Company Analysis
Latest News
🟢 GeneDx is trading 10.5% up today after Q2 revenue beat and return to adjusted profitability
GeneDx is trading approximately 10.5% up at $75.00 in pre-market trading today after reporting a return to adjusted profitability and a second-quarter revenue...
🟢 GeneDx is trading 6.8% up today after Q2 revenue beat and reaffirmed guidance
GeneDx is trading at $72.50 (+6.84%) after reporting Q2 revenue of $114.4 million, which exceeded analyst expectations and highlighted strong operational...
🟢 GeneDx is trading 12% up today after Q2 earnings beat and return to profitability
GeneDx is trading 12% up at $76.00 after reporting second-quarter 2026 revenue of $114.4 million, beating analyst estimates and returning to adjusted...
🔴 GeneDx is trading 8% down today after GAAP EPS miss and reaffirmed 2026 guidance
GeneDx is trading 8% down at $62.43 in after-hours trading following the release of its Q2 2026 financial results, which showed a wider-than-expected GAAP...
GeneDx's second quarter revenue of $114.4M beat estimates, driven by 32% growth in exome/genome volume.
GeneDx reported second quarter 2026 revenue of $114.4 million, an 11% increase year-over-year, beating analyst expectations. The company reported a GAAP loss...
🟢 GeneDx is trading 4.3% up today ahead of Q2 earnings release
GeneDx is trading 4.3% up at $67.91 as investors position ahead of its Q2 2026 earnings release. • Market attention is focused on upcoming results regarding...
🟢 GeneDx is trading 6% up today ahead of its Q2 2026 earnings release
GeneDx is trading 6% up at $69.01 in pre-market as investors position themselves ahead of the company's Q2 2026 earnings report. • Analysts are forecasting...
GeneDx Holdings Corp. Q2 2026 Earnings Preview: What Analysts Expect on August 03, 2026
Consensus expectations for the genomic diagnostics leader are $111.01 million in revenue and a $0.19 loss per share, with the stock currently trading at $68.93...
🔴 GeneDx is trading 4.8% down today amid broader biotech sector pressure
GeneDx is trading 4.8% down at $65.68 as the stock gives back gains from a recent rally amid broader biotech sector weakness. • The decline follows a sharp...
🟢 GeneDx is trading 4% up today, extending its rebound amid a broader tech-led market rally
GeneDx is trading 4% up at $66.24, extending a multi-session rebound as it tracks a broader tech-led market rally and improved risk sentiment. • The upward...
🟢 GeneDx is trading 5.9% up
GeneDx is trading at $65.52, up 5.9% from a comparison close of $61.88 during regular trading. This is a price-action follow-up, so a separate catalyst may not...
🟢 GeneDx is trading 4.8% up today as it extends its rebound from post-earnings volatility
GeneDx is trading 4.8% up at $63.47 as it extends its recovery following sharp post-earnings volatility earlier this quarter. • The move appears to reflect...
🟢 GeneDx rises 4.0% — Biotech Sector Rallies on Blockbuster M&A Deal and Positive Trial Data
With Biotech (XBI) up 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector is experiencing a significant...
🔴 GeneDx is trading 4.1% down today on ongoing securities fraud lawsuit concerns
GeneDx is trading 4.1% down at $60.77 as investors continue to digest the impact of ongoing securities fraud class action lawsuits tied to the Fabric Genomics...
GeneDx faces fraud lawsuit deadline, following 50% stock price crash
Law firms including Hagens Berman and Levi & Korsinsky set an August 3, 2026, lead plaintiff deadline for GeneDx Holdings Corp. investors. The securities fraud...
🔴 GeneDx is trading 4% down today amid ongoing pressure from weak guidance and a broader tech selloff
GeneDx is trading at $60.92 (-4.02%) as the stock faces continued pressure from recent weak guidance and a broader selloff in technology and growth names. •...
🔴 GeneDx is trading 4% down today amid sector weakness and prior earnings fallout
GeneDx is trading 4% down today at $63.47 as the stock faces pressure from broader biotech sector weakness and lingering sentiment from its recent financial...
🟢 GeneDx is trading 5.9% up
GeneDx is trading at $66.14, up 5.9% from a comparison close of $62.43 during regular trading. This is a price-action follow-up, so a separate catalyst may not...
🔴 GeneDx is trading 4.1% down today as post-earnings selloff continues on guidance cut and impairment
GeneDx is trading at $61.26 (4.1% down) as investors continue to digest weak first-quarter 2026 earnings, a revenue guidance cut, and a Fabric Genomics-related...
🔴 GeneDx is trading 4.4% down today amidst ongoing class action lawsuit alerts
GeneDx is trading at $66.32 (4.4% down) today, likely influenced by a series of recent class action lawsuit alerts against the company. These lawsuits, with...